THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE

被引：0
|
作者：
Palmaro, A. [1 ]
Despas, F. [1 ]
Lapeyre-Mestre, M. [1 ,2 ]
机构：
[1] CHU Toulouse, Univ Hosp, Med & Clin Pharmacol Unit, Toulouse, France
[2] Univ Toulouse, INSERM 1027, Pharmacoepidemiol Res Unit, Toulouse, France
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E65 / E65
页数：1
相关论文
共 50 条
  • [31] LENALIDOMIDE, MELPHALAN, PREDNISONE AND THALIDOMIDE (RMPT) FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Palumbo, A.
    Falco, P.
    Sanpaolo, G.
    Falcone, A.
    Ferderico, V.
    Canepa, L.
    Crugnola, M.
    Baldini, L.
    Caltagirone, S.
    Larocca, A.
    Gay, F.
    Magarotto, V.
    Petrucci, M. T.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 256 - 256
  • [32] Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma
    Zou, Yandun
    Sheng, Zhixin
    Niu, Shaona
    Wang, Huijuan
    Yu, Jinming
    Xu, Jingbo
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2219 - 2225
  • [33] Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?
    Mian, Michael
    Tinelli, Martina
    De March, Elena
    Turri, Gloria
    Meneghini, Vittorio
    Pescosta, Norbert
    Berno, Tamara
    Marabese, Alessandra
    Mondello, Patrizia
    Patriarca, Francesca
    Pizzolo, Giovanni
    Semenzato, Gianpietro
    Cortelazzo, Sergio
    Zambello, Renato
    ANTICANCER RESEARCH, 2016, 36 (03) : 1059 - 1065
  • [34] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [35] Thalidomide in elderly patients with multiple myeloma
    Kusumi, Eiji
    Matsumura, Tomoko
    Yuji, Koichiro
    Tanaka, Yuji
    Kami, Masahiro
    LANCET, 2006, 367 (9527): : 1977 - 1977
  • [36] Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide
    Rollison, Dana E.
    Komrokji, Rami
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Baz, Rachid
    Nishihori, Taiga
    Olesnyckyj, Marta
    Kenvin, Laurie
    Knight, Robert D.
    Sullivan, Daniel M.
    Alsina, Melissa
    Dalton, William
    Shain, Kenneth H.
    BLOOD, 2014, 124 (21)
  • [37] Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
    Huang, Phoebe A.
    Beedie, Shaunna L.
    Chau, Cindy H.
    Venzon, David J.
    Gere, Sheryl
    Kazandjian, Dickran
    Korde, Neha
    Mailankody, Sham
    Landgren, Ola
    Figg, William D.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations
    Caravita, Tommaso
    Offidani, Massimo
    Siniscalchi, Agostina
    Gentili, Silvia
    Caraffa, Patrizia
    Perrotti, Alessio
    de Fabritiis, Paolo
    Leoni, Pietro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) : 276 - 277
  • [39] Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide
    Rollison, Dana E.
    Komrokji, Rami
    Lee, Ji-Hyun
    Hampras, Shalaka
    Fulp, William
    Fisher, Kate
    Baz, Rachid
    Nishihori, Taiga
    Xu, Qiang
    Olesnyckyj, Marta
    Kenvin, Laurie
    Knight, Robert
    Sullivan, Daniel
    Alsina, Melissa
    Dalton, William
    Shain, Kenneth H.
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 560 - 568
  • [40] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
12345